Laos-ASEAN Pharmaceutical Sotoraxibu is launched

Sotoracib (AMG510) is developed by Amgen (Amgen), 2021 year05 On May28, it received accelerated approval from the U.S.FDA for the treatment of patients with KRAS who have received at least one systemic treatment in the past. Patients with G12Cmutated locally advanced or metastatic non-small cell lung cancer (NSCLC).

Currently, there are multiple versions of sotoracib overseas. 7month4 Japan ASEAN Pharmaceuticals produces sotoracib It is launched on the market with the specifications of 120 mg and 120 tablets. It is the only version of 120 tablets among the generic drugs that are officially on the market. The recommended dosage in the instructions is two boxes per month. The retail price of the drug factory is 5,000 to 6,000 per box, which is about 11,120 per box. ASEAN Pharmaceutical is a formal and qualified pharmaceutical factory in Laos, and the quality of its drugs is guaranteed.

The usual dose for adults with non-small cell lung cancer is960mg taken orally once daily and continued until disease progression or unacceptable toxicity. Follow all directions on your prescription label and read any medication guides or inserts carefully to use your medication as directed. Take your medicine at the same time every day with or without food. Swallow the tablet whole without crushing, chewing, or breaking it. If you cannot swallow the tablet whole, place it in a glass containing 4 ounces of water. Stir until the tablets are dispersed(It will not dissolve completely)and drink the mixture immediately or stir again and drink it within 2 hours. Do not chew tablets. Add 4 ounces of water to the glass, shake gently, and drink immediately. If you vomit soon after taking sotorasiib, do not take another dose and take your next dose as planned. If you want to get more high-quality information, you can contact YaDE. YaDE will do its best to learn more about high-quality overseas drugs for you.

xa0

xa0